Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 26 March 2020. Kevin Harper.

Executive Summary

The American Telemedicine Association expects CMS to provide additional support for telemedicine to help curb the spread of COVID-19. See what the organization's director of policy, Kevin Harper, said about the potential future of telemedicine here.

“There is probably going to have to be some sort of transition period. The goal here is to be able to collect as much data and understand the value that telehealth and virtual care provided during the pandemic so we can really come back and make permanent changes to the law." – Kevin Harper, director of policy, American Telemedicine Association

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel